We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 82.00 | 0.75% | 10,944.00 | 10,944.00 | 10,946.00 | 11,018.00 | 10,938.00 | 10,946.00 | 215,226 | 10:10:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 28.64 | 170.55B |
From Apr 2019 to Apr 2024
TIDMAZN
RNS Number : 9044W
AstraZeneca PLC
29 April 2016
ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2016
Results of Annual General Meeting held on 29 April 2016
AstraZeneca PLC announced the results of the voting at its Annual General Meeting today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and resolutions 9 - 11 were passed as special resolutions.
Hot Features
Premium
RESOLUTION VOTES FOR % OF VOTES VOTES % OF VOTES VOTES CAST TOTAL VOTES VOTES
CAST AGAINST CAST IN TOTAL CAST AS A % WITHHELD
OF ISSUED
SHARE
CAPITAL
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To receive the
Company's
Accounts and
the Reports of
the Directors
and Auditor
for the year
ended 31
1 December 2015 924,514,473 99.61 3,665,459 0.39 928,179,932 73.40% 8,998,621
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To confirm
2 dividends 933,191,043 99.69 2,915,972 0.31 936,107,015 74.03% 1,071,537
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
3 To re-appoint
KPMG LLP,
London as
Auditor 929,918,594 99.56 4,151,154 0.44 934,069,748 73.87% 3,108,804
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
4 To authorise
the Directors
to agree the
remuneration
of the Auditor 934,984,319 99.89 988,556 0.11 935,972,875 74.02% 1,204,865
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
5a To re-elect
Leif Johansson
as a Director 861,678,834 94.69 48,321,545 5.31 910,000,379 71.96% 27,177,942
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To re-elect
Pascal Soriot
5b as a Director 935,167,473 99.93 697,471 0.07 935,864,944 74.01% 1,342,796
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To re-elect
Marc Dunoyer
5c as a Director 931,875,086 99.58 3,920,615 0.42 935,795,701 74.00% 1,380,982
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To re-elect
Cori Bargmann
5d as a Director 935,157,654 99.93 635,873 0.07 935,793,527 74.00% 1,384,110
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
5e To re-elect
Geneviève
Berger as a
Director 935,199,102 99.93 622,099 0.07 935,821,201 74.00% 1,356,436
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
5f To re-elect
Bruce
Burlington as
a Director 933,026,505 99.70 2,762,355 0.30 935,788,860 74.00% 1,389,088
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To re-elect
Ann Cairns as
5g a Director 933,220,149 99.72 2,618,183 0.28 935,838,332 74.01% 1,339,989
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
5h To re-elect
Graham
Chipchase as a
Director 919,686,570 98.97 9,526,012 1.03 929,212,582 73.48% 7,965,366
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
5i To re-elect
Jean-Philippe
Courtois as a
Director 933,177,891 99.72 2,593,420 0.28 935,771,311 74.00% 1,406,637
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To re-elect
Rudy Markham
5j as a Director 923,984,532 98.74 11,766,347 1.26 935,750,879 74.00% 1,427,442
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
To re-elect
Shriti Vadera
5k as a Director 927,479,182 99.11 8,287,726 0.89 935,766,908 74.00% 1,410,552
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
5l To re-elect
Marcus
Wallenberg as
a Director 870,828,312 95.76 38,511,577 4.24 909,339,889 71.91% 27,837,158
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
6 To approve the
Annual Report
on
Remuneration
for the year
ended 31
December 2015 836,396,151 89.61 96,959,428 10.39 933,355,579 73.81% 3,822,290
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
7 To authorise
limited EU
political
donations 908,106,542 97.83 20,185,176 2.17 928,291,718 73.41% 8,886,009
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
8 To authorise
the Directors
to allot
shares 849,809,843 90.97 84,303,774 9.03 934,113,617 73.87% 3,064,122
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
9 To authorise
the Directors
to disapply
pre-emption
rights 922,425,478 98.82 11,009,374 1.18 933,434,852 73.82% 3,742,888
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
10 To authorise
the Company to
purchase its
own shares 926,166,577 98.96 9,722,078 1.04 935,888,655 74.01% 1,289,613
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
11 To reduce the
notice period
for general
meetings 829,946,353 88.85 104,116,202 11.15 934,062,555 73.87% 3,115,081
--- --------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------
Issued capital
As at 27 April 2016, the number of issued shares of the Company was 1,264,542,488 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.
A C N Kemp
Company Secretary
29 April 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGPGUGACUPQGAB
(END) Dow Jones Newswires
April 29, 2016 12:30 ET (16:30 GMT)
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
